Clin2
NCT06914557Possibly a fitRecruiting

Scrambler therapy plus duloxetine for chemo nerve pain

CIPN - Chemotherapy-Induced Peripheral NeuropathyPain

Part of Pain clinical trials.

This study tests whether adding a non-invasive device called Scrambler Therapy to the usual nerve pain medicine (duloxetine) can better relieve chemotherapy-induced nerve pain. It is for people with cancer who still have significant nerve pain despite taking duloxetine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have had cancer
  • You have nerve pain or numbness in your hands or feet that started or got worse after chemotherapy
  • You are already taking duloxetine (Cymbalta) at least 30 mg daily for at least 4 weeks
  • Your average nerve pain level is at least 4 out of 10
  • You are not taking gabapentin (unless you can safely stop) and do not have a pacemaker or other implanted device
  • You are not pregnant, nursing, or have severe depression or epilepsy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07219472Recruiting
Scrambler therapy for nerve pain from chemotherapy

This trial tests a non-invasive treatment called Scrambler Therapy for pain caused by nerve damage from chemotherapy. If you have had this kind of pain for at least 3 months, this therapy might help reduce it without using more drugs.

Cleveland, Ohio
NCT04970121Recruiting· Phase 2
Duloxetine for chemotherapy nerve pain in solid tumor patients

This Phase 2 trial tests duloxetine to see if it safely reduces painful nerve damage caused by chemotherapy (especially taxanes) in people with solid tumors. If you have moderate-to-severe nerve pain and meet lab and heart-safety checks, this study may be an option.

Bengbu, Anhui
NCT07264920Not yet recruiting
Pain relief study for kids with nerve pain

This study tests a device that uses mild electrical pulses to reduce nerve pain in children with cancer. It may offer a drug-free way to manage pain.

Baltimore, Maryland
NCT06522685Not yet recruiting
Brain stimulation for chemotherapy nerve pain

This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.

Baltimore, Maryland
NCT07174609Recruiting
Scrambler therapy for chronic pancreatitis pain

This study tests a non-invasive pain treatment called scrambler therapy for people with chronic pancreatitis. It uses mild electrical signals on the skin to try to reduce long-term belly pain.

Baltimore, Maryland
NCT06596200Not yet recruiting· Phase 4
Spinal nerve stimulation for chemo-related nerve pain

This study tests a spinal cord stimulator—a device that sends mild electrical pulses to the spine—to see if it can reduce severe nerve pain that lasts more than 6 months after chemotherapy. It is for people who have tried other treatments like duloxetine but still have significant pain.

Hear when a new Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.